These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7109642)

  • 21. Cyclical combination chemotherapy for advanced breast carcinoma.
    Canellos GP; Devita VT; Gold GL; Chabner BA; Schein PS; Young RC
    Br Med J; 1974 Feb; 1(5901):218-20. PubMed ID: 4818162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved remission rates and remission duration in young women with metastatic breast cancer following combined oophorectomy and chemotherapy: a study of Cancer and Leukemia Groupe B.
    Falkson G; Falkson HC; Glidewell O; Weinberg V; Leone L; Holland JF
    Cancer; 1979 Jun; 43(6):2215-22. PubMed ID: 378348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy.
    Wendt AG; Jones SE; Salmon SE
    Cancer Treat Rep; 1980; 64(2-3):269-73. PubMed ID: 6893293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Present indication for endocrine therapy and chemotherapy in advanced breast cancer.
    Heuson JC; Leclercq G; Mattheiem WH
    Antibiot Chemother (1971); 1978; 24():189-204. PubMed ID: 350136
    [No Abstract]   [Full Text] [Related]  

  • 25. [Endocrine therapy of recurrent breast cancer].
    Nomura Y; Tashiro H
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):421-7. PubMed ID: 3890756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictability of response to endocrine ablation in breast cancer.
    Criss WE; Bland KI; O'Leary JP
    South Med J; 1975 Jun; 68(6):714-6. PubMed ID: 166448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: report of the Swiss Group for Clinical Cancer Research.
    Cavalli F; Beer M; Martz G; Jungi WF; Alberto P; Obrecht JP; Mermillod B; Brunner KW
    Br Med J (Clin Res Ed); 1983 Jan; 286(6358):5-8. PubMed ID: 6401458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of four-combination chemotherapy programs in metastatic breast cancer: comparison of multiple drug therapy with cytoxan, 5-FU and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-FU and adriamycin, versus cytoxan, 5-FU and prednisone alternating with cytoxan and adriamycin.
    Nemoto T; Horton J; Simon R; Dao TL; Rosner D; Cunningham T; Sponzo R; Snyderman M
    Cancer; 1982 May; 49(10):1988-93. PubMed ID: 7074523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of oophorectomy by menstrual and estrogen receptor states in patients with metastatic breast cancer.
    Peetz ME; Awrich AE; Moseley HS; Keenan EJ; Davenport CE; Fletcher WS
    Am J Surg; 1981 May; 141(5):554-8. PubMed ID: 7223947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management of advanced breast cancer.
    Baum M
    Br J Hosp Med; 1980 Jan; 23(1):32, 35, 37-9. PubMed ID: 6153539
    [No Abstract]   [Full Text] [Related]  

  • 31. Estrogen receptors in hormone-dependent breast cancers.
    Jensen EV
    Cancer Res; 1975 Nov; 35(11 Pt. 2):3362-4. PubMed ID: 172222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
    Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor in breast cancer of the Japanese.
    Nomura Y
    Gan; 1976 Oct; 67(5):703-11. PubMed ID: 190078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in endocrine treatments for postmenopausal women with metastatic and early breast cancer.
    Buzdar AU
    Oncologist; 2003; 8(4):335-41. PubMed ID: 12897330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical management of metastatic breast cancer.
    Lawrence W; Brown PW; Terz JJ
    Surgery; 1977 Aug; 82(2):173-81. PubMed ID: 69328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiestrogen-induced remissions in stage IV breast cancer.
    Manni A; Trujillo J; Marshall JS; Pearson OH
    Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tamoxifen and oophorectomy in the treatment of recurrent breast cancer: a Southwest Oncology Group Study.
    Hoogstraten B; Fletcher WS; Gad-el-Mawla N; Maloney T; Altman SJ; Vaughn CB; Foulkes MA
    Cancer Res; 1982 Nov; 42(11):4788-91. PubMed ID: 7127314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged remissions of metastatic breast cancer achieved with a six-drug regimen of relatively low toxicity.
    Hirshaut Y; Kesselheim H
    Cancer; 1983 Jun; 51(11):1998-2004. PubMed ID: 6687698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bilateral adrenalectomy in treatment of disseminated breast cancer.
    Galbut DL; Wallack MK; Brown AS; Rosato E; Johnson J; Rosato FE
    Am J Surg; 1976 Mar; 131(3):267-9. PubMed ID: 56896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Certain aspects of the medical management of metastatic breast cancer.
    Abeloff MD
    Johns Hopkins Med J; 1974 Feb; 134(2):84-9. PubMed ID: 4811013
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.